Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

被引：0
|
作者：
Sam Razavi
Laurent Kodjikian
Audrey Giocanti-Aurégan
Ingrid Dufour
Eric Souied
机构：
[1] Centre d’Ophtalmologie,
[2] Centre Hospitalier de la Cr Rousse,undefined
[3] Université de Lyon,undefined
[4] Hôpital Avicenne,undefined
[5] AP-HP,undefined
[6] Université Paris 13,undefined
[7] DHU Vision et Handicaps,undefined
[8] Bayer HealthCare SAS,undefined
[9] Centre Hospitalier Intercommunal de Créteil,undefined
来源：
BMC Ophthalmology | / 21卷
关键词：
Retina; Age-related macular degeneration; Exudative; Switch; Observational;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Subgroup Analyses From the VIEW Trials
    Wong, Tien Yin
    Cheung, Chui Ming Gemmy
    Lai, Timothy Y. Y.
    Chen, Shih-Jen
    Lee, Won Ki
    Yoon, Young Hee
    Iida, Tomohiro
    Tueckmantel, Claudia
    Sowade, Olaf
    Ogura, Yuichiro
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (03): : 537 - 547
  • [12] Response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory ranibizumab
    Ogata, N.
    Hasegawa, T.
    Yamashita, M.
    Okamoto, M.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [13] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [14] Aflibercept for Intravitreal InjectionIn Neovascular Age-Related Macular Degeneration
    James E. Frampton
    Drugs & Aging, 2012, 29 : 839 - 846
  • [15] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Dae Hyun Park
    Hae Jung Sun
    Sung Jin Lee
    International Ophthalmology, 2017, 37 : 1205 - 1214
  • [16] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Park, Dae Hyun
    Sun, Hae Jung
    Lee, Sung Jin
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (05) : 1205 - 1214
  • [17] Efficacy of intravitreal aflibercept treatment of pigment epithelial detachment in neovascular age-related macular degeneration refractory to intravitreal ranibizumab: 2-year outcomes
    Ramskold, Louise
    Lee, Han Bin
    Chandran, Manju N.
    Gencheva, Petya
    Menon, Geeta
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [18] Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration
    Sizmaz, Selcuk
    Esen, Ebru
    Isik-Ericek, Puren
    Demircan, Nihal
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2022, 105 (01) : 55 - 60
  • [19] Conversion to aflibercept for patients with neovascular age-related macular degeneration who were refractory to ranibizumab treatment
    Kawashima, Yu
    Oishi, Akio
    Miyake, Masahiro
    Yoshikawa, Munemitsu
    Takahashi, Ayako
    Ueda, Naoko
    Tamura, Hiroshi
    Yamashiro, Kenji
    Tsujikawa, Akitaka
    Yoshimura, Nagahisa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [20] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Marquis, Liza-Marie
    Mantel, Irmela
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1591 - 1596
12345